![Daniel Yadegar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Yadegar
Directeur/Membre du Conseil chez
LUMOS PHARMA, INC.
Profil
Daniel Yadegar is the founder of Newpath Management LP, founded in 2018.
Dr. Yadegar currently holds the positions of Director at Lumos Pharma, Inc. and Managing Partner at Double Point Ventures LLC.
Dr. Yadegar completed undergraduate education at Harvard University in 1999 and graduate education at Weill Cornell Medical College in 2004.
Postes actifs de Daniel Yadegar
| Sociétés | Poste | Début |
|---|---|---|
| LUMOS PHARMA, INC. | Directeur/Membre du Conseil | - |
Newpath Management LP
 Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Fondateur | 01/09/2018 |
Formation de Daniel Yadegar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newpath Management LP
Newpath Management LP Investment ManagersFinance Newpath Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and life sciences sectors. It provides financing for early stage capital requirements. | Finance |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
